Harvest Fund Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4K | Buy |
+24
| New | +$4.42K | ﹤0.01% | 471 |
|
|
2025
Q4 | – | Sell |
-8,998
| Closed | -$1.47M | – | 602 |
|
|
2025
Q3 | $1.26M | Buy |
8,998
+679
| +8% | +$91.8K | 0.05% | 174 |
|
|
2025
Q2 | $1.04M | Sell |
8,319
-927
| -10% | -$116K | 0.05% | 183 |
|
|
2025
Q1 | $1.26M | Buy |
9,246
+670
| +8% | +$95.8K | 0.06% | 174 |
|
|
2024
Q4 | $1.12M | Buy |
8,576
+1,866
| +28% | +$315K | 0.05% | 200 |
|
|
2024
Q3 | $1.3M | Buy |
6,710
+2,304
| +52% | +$482K | 0.08% | 161 |
|
|
2024
Q2 | $1.02M | Buy |
4,406
+126
| +3% | +$27.4K | 0.07% | 163 |
|
|
2024
Q1 | $923K | Buy |
4,280
+2,990
| +232% | +$700K | 0.08% | 154 |
|
|
2023
Q4 | $329K | Buy |
1,290
+133
| +11% | +$32.7K | 0.05% | 161 |
|
|
2023
Q3 | $297K | Buy |
1,157
+429
| +59% | +$115K | 0.05% | 164 |
|
|
2023
Q2 | $207K | Buy |
728
+200
| +38% | +$59.5K | 0.04% | 196 |
|
|
2023
Q1 | $147K | Sell |
528
-31
| -6% | -$8.58K | 0.03% | 256 |
|
|
2022
Q4 | $154K | Buy |
559
+499
| +832% | +$141K | 0.04% | 253 |
|
|
2022
Q3 | $16K | Buy |
60
+28
| +88% | +$5.95K | ﹤0.01% | 576 |
|
|
2022
Q2 | $7K | Hold |
32
| – | – | ﹤0.01% | 646 |
|
|
2022
Q1 | $6K | Hold |
32
| – | – | ﹤0.01% | 685 |
|
|
2021
Q4 | $7K | Sell |
32
-67
| -68% | -$17.2K | ﹤0.01% | 713 |
|
|
2021
Q3 | $28K | Buy |
+99
| New | +$32.4K | 0.01% | 541 |
|
|
2020
Q4 | – | Sell |
-73
| Closed | -$20K | – | 586 |
|
|
2020
Q3 | $20K | Buy |
+73
| New | +$20.4K | ﹤0.01% | 480 |
|
|
2020
Q2 | – | Sell |
-725
| Closed | -$229K | – | 459 |
|
|
2020
Q1 | $229K | Sell |
725
-153
| -17% | -$46.4K | 0.03% | 111 |
|
|
2019
Q4 | $257K | Buy |
878
+729
| +489% | +$202K | 0.03% | 90 |
|
|
2019
Q3 | $35K | Sell |
149
-484
| -76% | -$113K | ﹤0.01% | 327 |
|
|
2019
Q2 | $148K | Buy |
633
+350
| +124% | +$80.8K | 0.02% | 145 |
|
|
2019
Q1 | $67K | Sell |
283
-621
| -69% | -$196K | 0.01% | 245 |
|
|
2018
Q4 | $272K | Buy |
904
+520
| +135% | +$166K | 0.06% | 83 |
|
|
2018
Q3 | $136K | Buy |
384
+211
| +122% | +$72.6K | 0.02% | 229 |
|
|
2018
Q2 | $50K | Hold |
173
| – | – | 0.01% | 189 |
|
|
2018
Q1 | $47K | Hold |
173
| – | – | 0.01% | 172 |
|
|
2017
Q4 | $55K | Sell |
173
-172
| -50% | -$55.2K | 0.01% | 164 |
|
|
2017
Q3 | $108K | Buy |
345
+244
| +242% | +$72.3K | 0.01% | 90 |
|
|
2017
Q2 | $27K | Sell |
101
-287
| -74% | -$75.9K | ﹤0.01% | 194 |
|
|
2017
Q1 | $106K | Hold |
388
| – | – | 0.02% | 85 |
|
|
2016
Q4 | $110K | Buy |
+388
| New | +$115K | 0.02% | 96 |
|
Other funds holding BIIB
VCM
VPM
Harvest Fund Management's BIIB Position: Q1 2026 in Review
Harvest Fund Management opened a new position in Biogen (BIIB) in Q1 2026: 24 shares worth $4K. The stake represents ﹤0.01% of the portfolio and ranks #471 among its holdings. This is a return to the name: Harvest Fund Management previously reported a position in BIIB as recently as Q3 2025.
Harvest Fund Management first reported a position in BIIB in Q4 2016 and has held it in 33 quarters since. The position peaked at $1.3M in Q3 2024. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Harvest Fund Management held 24 shares of Biogen worth $4K as of Q1 2026.
- Biogen was a new Harvest Fund Management position in Q1 2026.
- Biogen made up ﹤0.01% of Harvest Fund Management's portfolio in Q1 2026, its #471 holding.
- Harvest Fund Management first reported a position in Biogen in Q4 2016 and has held it in 33 quarters since.
- Harvest Fund Management's Biogen position peaked at $1.3M in Q3 2024.
- 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Harvest Fund Management's 13F filing for Q1 2026, filed 14 May 2026.